|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date04 Jan 1960 |
评估玻璃体内注射用曲安奈德在玻璃体手术中用于玻璃体可视化的有效性和安全性的多中心临床研究
[Translation] A multicenter clinical study to evaluate the efficacy and safety of intravitreal triamcinolone acetonide for vitreous visualization during vitreous surgery
主要目的:评估玻璃体内注射用曲安奈德在玻璃体手术中用于玻璃体可视化的有效性。
次要目的:评估玻璃体内注射用曲安奈德在玻璃体手术中用于玻璃体可视化的安全性。
[Translation] Primary objective: To evaluate the effectiveness of intravitreal triamcinolone acetonide for vitreous visualization during vitreous surgery.
Secondary objective: To evaluate the safety of intravitreal triamcinolone acetonide for vitreous visualization during vitreous surgery.
100 Clinical Results associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
100 Deals associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shenzhen Rosso Pharmaceutical Co., Ltd.